Hotsia.Com : เที่ยวสะใจ

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

---

How does standardized CKD screening (eGFR + ACR) in diabetes/hypertension improve detection, what implementation studies show, and how does this compare with opportunistic testing?

Standardized chronic kidney disease (CKD) screening, using both the estimated Glomerular Filtration Rate (eGFR) and the urine Albumin-to-Creatinine Ratio (ACR), dramatically improves early detection in people with diabetes and hypertension by providing a more complete picture of kidney health than either test alone. This systematic approach uncovers hidden kidney damage that would be missed by less organized, opportunistic testing. Implementation studies confirm that structured screening programs increase the identification of early-stage CKD, allowing for timely interventions that can slow disease progression.

How Standardized Screening (eGFR + ACR) Improves Detection 🩺

Chronic Kidney Disease is often called a “silent” disease because it can progress for years without any noticeable symptoms. For high-risk individuals, such as those with diabetes and hypertension, early detection is crucial to preventing or delaying kidney failure. Standardized screening, which combines two simple tests, is the key to uncovering this hidden danger.

The eGFR (estimated Glomerular Filtration Rate) is a blood test that measures how well the kidneys are filtering waste from the blood. It essentially assesses the function of the kidneys. A declining eGFR indicates that kidney function is worsening.

The ACR (urine Albumin-to-Creatinine Ratio) is a urine test that checks for albumin, a type of protein. Healthy kidneys do not let significant amounts of albumin pass into the urine. The presence of albuminuria is a primary marker of kidney damage.

Using only one of these tests provides an incomplete picture. A person can have a normal eGFR (good kidney function) but still have significant albuminuria (kidney damage), which is an early sign of diabetic kidney disease. Conversely, an older individual might have a slightly lower eGFR due to age but no albuminuria. By combining the two tests, clinicians can detect CKD far more accurately and much earlier. This dual assessment allows for the identification of kidney damage even when filtration function appears normal, enabling interventions to begin before irreversible functional loss occurs. This systematic approach catches the disease in its earliest, most treatable stages.

What Implementation Studies Reveal 📊

Real-world implementation studies consistently show that systematic, standardized screening significantly boosts the rate of CKD detection compared to disorganized approaches. Before the push for standardized screening, many high-risk patients would only have their kidney function checked sporadically or when symptoms arose, which is often too late.

Studies focused on primary care settings reveal several key findings:

• Underdiagnosis is Rampant Without a System: Research consistently shows that a large percentage of patients with diabetes and hypertension are not screened according to guidelines when testing is left to individual clinician discretion. Specifically, the ACR test is frequently overlooked.
• Systematic Prompts Work: When healthcare systems implement electronic health record (EHR) reminders, automated ordering panels (a “kidney profile”), or nurse-led screening protocols, the rates of both eGFR and ACR testing increase dramatically. This leads to a corresponding rise in the diagnosis of early-stage CKD.
• Early Diagnosis Leads to Early Treatment: Implementation studies have demonstrated that once a standardized screening program is in place and more cases of early CKD are identified, there is an associated increase in the prescription of protective medications, such as ACE inhibitors, ARBs, and SGLT2 inhibitors. These medications are proven to slow the progression of kidney disease and reduce cardiovascular risk.
• Cost-Effectiveness in High-Risk Groups: Economic analyses have shown that systematic screening for CKD in patients with diabetes and hypertension is highly cost-effective. The cost of regular screening is far outweighed by the savings from delaying or preventing the need for dialysis or kidney transplantation, which are incredibly expensive treatments.

These studies confirm that moving from a passive to an active screening strategy is essential for closing the gap in CKD care and improving patient outcomes.

Comparison with Opportunistic Testing 🤔

The difference between standardized screening and opportunistic testing is the difference between a planned, proactive strategy and a reactive, haphazard one.

Opportunistic testing occurs when a doctor decides to check kidney function on a case-by-case basis, perhaps because a patient mentions a new symptom or because they happen to be getting other bloodwork done. This approach is highly unreliable for a silent disease like CKD. It relies on chance and often misses the crucial window for early intervention. High-risk individuals can go years without a proper kidney health check, allowing irreversible damage to occur unnoticed. The ACR test is almost universally neglected in an opportunistic model, meaning the earliest signs of kidney damage are consistently missed.

Standardized screening, in contrast, is a systematic, guideline-driven approach. It mandates that every patient with a known risk factor, like diabetes or hypertension, receives an annual eGFR and ACR test, regardless of whether they have symptoms. This proactive method ensures a consistent and comprehensive evaluation of kidney health across the entire at-risk population.

Feature	Standardized Screening (eGFR + ACR)	Opportunistic Testing
Approach	Proactive, systematic, and population-based	Reactive, haphazard, and individual-based
Timing	Regular, scheduled intervals (e.g., annually)	Irregular, based on chance or symptoms
Completeness	Uses both eGFR and ACR for a full assessment	Often relies only on eGFR, missing early damage
Detection Rate	High, especially for early-stage CKD	Low, often diagnoses at later, more severe stages
Outcome	Facilitates early intervention, slowing disease progression	Leads to delayed diagnosis and worse long-term outcomes
Guideline Adherence	High	Low

In conclusion, standardized CKD screening with both eGFR and ACR is vastly superior to opportunistic testing for patients with diabetes and hypertension. It transforms CKD from a disease discovered late into a manageable long-term condition by systematically identifying it early, enabling the prompt initiation of therapies that can preserve kidney function and improve overall health for years to come.

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. I share my experiences on www.hotsia.com